Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Prefilled Syringes Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Material (Glass Syringes, Plastic Syringes), By Application (Anaphylaxis, Diabetes), End Use, By Region, And Segment Forecasts, 2022 - 2030
... Market Growth & Trends The global prefilled syringes market size is anticipated to reach USD 50.83 billion by 2030, expanding at a CAGR of 11.95% from 2022 to 2030, according to a new report by ... Read More
-
Global Human Insulin Market Size study, By Product Type (Insulin Analogs and Biosimilars (Rapid-acting, Long-acting, Premixed), Human Insulin Biologics (Short-acting, Intermediate-acting, Premixed)), By Type (Insulin Analogs and Biosimilars (Long-Acting Biosimilars, Rapid-Acting Biosimilars, Premixed Biosimilars), HI Biologics (Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics)), By Delivery Devices (Pens, Pen Needles, Syringes), By Brand (Insulin Analogs and Biosimilars (Lantus, NovoRapid/Novolog, Humalog, Other Brands), Human Insulin Biologics (Actrapid, Insulatard, and Mixtard, Humulin, Insuman)), By Application (Type I Diabetes, Type II Diabetes), and Regional Forecasts 2022-2028
... Biologics (Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics)), By Delivery Devices (Pens, Pen Needles, Syringes), By Brand (Insulin Analogs and Biosimilars (Lantus, NovoRapid/Novolog, Humalog, Other Brands), Human Insulin Biologics (Actrapid, Insulatard, and Mixtard, Humulin, Insuman)), By ... Read More
-
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028
... Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, ... Read More
-
Diabetes Supplements Market (Type: Vitamins, Minerals, Proteins, Antioxidant & Fatty Acids, Dietary Fibers, and Others; Disease Type: Type 1 and Type 2; Dosage Form: Tablets, Solution, Powder, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 Diabetes Supplements Market – Scope of Report TMR’s report on the global diabetes supplements market studies the past as well ... Read More
-
Europe Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The Europe digital therapeutics market is expected to reach US$ 1,338.13 million by 2028 from US$ 1,023.59 million in 2021; it is estimated to grow at a CAGR of 22.9% from ... Read More
-
Asia Pacific Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The Asia Pacific digital therapeutics market is expected to reach US$ 3,470.31 million by 2028 from US$ 767.23 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
Insulin Pumps and Continuous Glucose Monitors Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030
... (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area. The model discusses in ... Read More
-
2022 Global Diabetes Care Devices Industry (2028 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total ... Read More
-
Smart Insulin Pens Market By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020-2030
... The global smart insulin pens market was valued at $94.8 million in 2020, and is estimated to reach $298.9 million by 2030, growing at a CAGR of 12.2% from 2021 to 2030. Smart insulin pens ... Read More
-
2022 Global Digital Diabetes Management Industry (2028 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total ... Read More
-
Global Diabetic Footwear Market Databank
... Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is anticipated ... Read More
-
Leading Diabetic Footwear End Use Markets Databank
... to 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment ... Read More
-
Europe Diabetic Footwear Market Databank
... Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is anticipated ... Read More
-
Leading Diabetic Footwear Country Markets Databank
... 2029. North America is expected to be the highest contributor to this market, with $2,250.6 Million in 2020, and is anticipated to reach $3,867.7 Million by 2029, registering a CAGR of 6.24%. Asia-Pacific is anticipated ... Read More
-
Leading Diabetic Footwear Product Markets Databank
... 2029. Shoes segment is expected to be the highest contributor to this market, with $2,508.8 Million in 2020, and is anticipated to reach $4,260.1 Million by 2029, registering a CAGR of 6.10%. Sandals segment is ... Read More
-
North America Diabetic Footwear Market Databank
... 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is ... Read More
-
Latin America, Middle East & Africa Diabetic Footwear Market Databank
... 6.09% from 2021 to 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Diabetic Footwear Market Databank
... Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is anticipated ... Read More
-
Insulin Resistance Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Insulin Resistance (Metabolic Disorders) pipeline landscape. Insulin resistance (IR) is a condition in which the body's cells become resistant ... Read More
-
Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type ... Read More
-
Diabetic Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Macular Edema (Metabolic Disorders) pipeline landscape. Diabetic macular edema (DME) occurs when blood vessels in the ... Read More
-
Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030
... SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Insulin Pens ... Read More
-
Dual Chamber Pre-Filled Syringes Market Report 2022-2032
... and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Dual Chamber syringes have a number of ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the ... Read More
Research Assistance
